ClinicalTrials.Veeva

Menu

Rule Out of ACS in Primary Care Using a Decision Rule for Chest Pain Including Hs-troponin I POCT (POB HELP)

L

Leiden University Medical Center (LUMC)

Status

Completed

Conditions

Acute Coronary Syndrome
Chest Pain
Myocardial Infarction

Treatments

Diagnostic Test: Clinical decision rule

Study type

Interventional

Funder types

Other

Identifiers

NCT05827237
p20.013

Details and patient eligibility

About

The goal of this clustered, diagnostic randomized controlled trial is to study a clinical decision rule including a high-sensitive troponin I point of care test in patients with chest pain in primary care.

The main questions it aims to answer are:

  1. Can unnecessary referrals to secondary care be reduced by the use of a clinical deci-sion rule in patients with new onset, non-traumatic chest pain in primary care? Compared to current daily practice.
  2. What is the accuracy (sensitivity, negative prediction value) of the clinical decision rule for excluding ACS and MACE at 6 weeks and 6 months?

Full description

This clustered, diagnostic randomized controlled trial will included patients with acute chest pain consulting their general practitioner. Practices in the intervention group will use a clinical decision rule consisting of the Marburg Heart Score and a high-sensitive troponin I point of care test to exclude acute coronary syndrome (ACS) and decide upon referral. Practices in the control group will apply usual care following local guidelines.

An independent endpoint committee consisting of a cardiologist and general practitioner will adjudicate the final diagnosis. Primary endpoints are ACS and Major Adverse Cardiac Events. A delayed reference standard of 6 months will be used.

For high sensitive troponin I measurement, the Siemens Atellica VTLi immunoassay analyser is used.

Enrollment

946 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • ≥18 years of age
  • Acute chest pain
  • Seen by general practitioner

Exclusion criteria

  • <1 hour since onset of symptoms
  • Inability to speak or understand Dutch
  • Hemodynamic instability

Trial design

Primary purpose

Diagnostic

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

None (Open label)

946 participants in 2 patient groups

Clinical decision rule
Experimental group
Description:
Patients in whom the clinical decision rule is used to exclude acute coronary syndrome
Treatment:
Diagnostic Test: Clinical decision rule
Standard care
No Intervention group
Description:
Patients in whom the general practitioner decides upon referral following local guidelines.

Trial contacts and locations

1

Loading...

Central trial contact

Tobias Bonten, MD PhD; Simone van den Bulk, MD

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems